Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-06 to 2024-03-07
Current total value of award: $2678.34
Description: 4563903881!ORALAIR 300 IR SUBLINGUAL TAB 30S